Search results for: 'land-based weather radar'

The aim of this research service is to analyse the diabetes diagnostics market in Europe and provide strategic recommendations and conclusions for the success of its participants. The main objective of this research service is to establish an understanding of the key diabetes diagnostics market segments (laboratory-based HbA1C diagnostics, SMBG and...

This research service studies the Indian Diabetes market. It provides the number of Type 1 and Type 2 diabetic patients in India across different age groups and forecasts these numbers up to 2030. It provides a detailed analysis of the two major segments of the market, the insulin market segment and the anti-diabetic medications segment, which incl...

01 Jul 2015  |  North America  |  Market Research

Analysis of the US and European Diabetes Diagnostics Market

Constricting Reimbursement Policies Restrain Market Growth

Infographics

×

The diabetes diagnostics markets in the United States and Europe have been in a mature stage for many years. Growth is sustained due to the high prevalence of diabetes in both regions. The segments covered in the study are self-monitoring of blood glucose (SMBG), point-of-care testing (POCT), and lab-based HbA1c testing. The emerging market of non-...

The diabetes diagnostics market in South Korea is classified into two market segments as laboratory diabetes diagnostics segment and POCT diabetes diagnostics segment. The analysis time frame for this study was from 2002 to 2012, with 2005 being the base year of the study. The forecast period is 2006 to 2012 and historic period is 2002 to 2004.

The diabetes diagnostics market in China is classified into two market segments as laboratory diabetes diagnostics segment and POCT diabetes diagnostics segment. The analysis time frame for this study was from 2005 to 2012{CAGR period}, with 2005 being the base year of the study. The forecast period is 2006 to 2012 and historic period is 2002 to 20...

Diabetes has exhibited dramatic increases during the past decade, registering a global prevalence of 9% among adults aged 18 years and older, and is projected to be the 7th-leading cause of death by 2030. The most popular treatment for type 1 diabetes mellitus (T1DM) is multiple daily insulin (MDI) injections. However, researchers globally are work...